Centrus Energy Soars 202% YTD: Buy, Sell or Hold the Stock?

Centrus Energy (LEU) stock has soared 202.4% year-to-date in 2025, largely due to its first-mover advantage as the Western world's sole licensed High-Assay, Low-Enriched Uranium (HALEU) producer and strategic partnerships aimed at expanding enrichment capacity, supported by a $3.6 billion revenue backlog through 2040. Despite this strong long-term outlook and successful HALEU deliveries to the DOE, the company reported an 18% year-over-year Q2 revenue decline, elevated debt, and a stretched valuation (7.55x forward P/S vs. industry 2.86x), with analysts projecting earnings declines for 2025 and 2026, suggesting caution for new investors despite the promising HALEU market growth.

Analysis

Centrus Energy (LEU) has demonstrated extraordinary market outperformance, with its stock surging 202.4% year-to-date, fueled by its strategic position as the sole licensed producer of High-Assay, Low-Enriched Uranium (HALEU) in the Western world. This position is reinforced by key operational and strategic milestones, including the delivery of 920 kilograms of HALEU under a U.S. Department of Energy (DOE) contract, which has been extended through June 2026, and a new MOU with KHNP and POSCO to attract private capital for capacity expansion. The company's long-term revenue visibility is strong, supported by a $3.6 billion order backlog with contracts extending to 2040, aligning with projections of the HALEU market growing to $6.14 billion by 2035. However, this bullish long-term narrative is tempered by significant near-term headwinds and financial risks. The company reported an 18% year-over-year decline in Q2 revenue and a 16% drop in earnings per share, driven by a 27% fall in SWU sales volumes. Furthermore, the stock's valuation appears stretched, with a forward price-to-sales multiple of 7.55X, well above the industry average of 2.86X. Compounding these concerns are a high total debt-to-capital ratio of 0.55, which is substantially greater than peers, and consensus analyst estimates that project year-over-year earnings declines of 5.37% in 2025 and 20.6% in 2026.

Key Decisions for Investors

• Existing investors may consider holding their position to realize long-term value from Centrus Energy's first-mover advantage in the HALEU market and its secured $3.6 billion revenue backlog.
• Prospective investors should be cautious of the stock's stretched valuation and projected near-term earnings declines, and may wish to await a more favorable entry point or evidence of improved quarterly performance.
• Monitor the company's effort to secure U.S. Department of Energy funding and private capital for its Piketon plant expansion, as this is a critical catalyst for future growth and a dependency for key supply agreements.
• Scrutinize the company's elevated debt-to-capital ratio of 0.55 as a primary risk factor, particularly in comparison to the stronger balance sheets of industry peers like Cameco and Energy Fuels.